Weight Loss Supplement-Induced Pulmonary Hypertension: A Decades Delayed Presentation of Fenfluramine-Phentermine
Am J Ther
.
2023 May 1;30(3):e300-e301.
doi: 10.1097/MJT.0000000000001387.
Authors
Mitra Patel
1
,
Judy Daboul
1
,
Saffa Iftikhar
1
,
Cameron Burmeister
1
,
Amala Ambati
1
,
George Moukarbel
2
,
Ragheb Assaly
3
Affiliations
1
Departments of Internal Medicine.
2
Cardiology.
3
Pulmonary and Critical Care Medicine, University of Toledo, Toledo, OH.
PMID:
34117142
DOI:
10.1097/MJT.0000000000001387
No abstract available
Publication types
Letter
MeSH terms
Fenfluramine / adverse effects
Humans
Hypertension, Pulmonary* / chemically induced
Hypertension, Pulmonary* / diagnosis
Hypertension, Pulmonary* / drug therapy
Obesity
Phentermine* / adverse effects
Weight Loss
Substances
Phentermine
Fenfluramine